Evidence map›Paper›PMID 26751771›Full record

ArticleOncogene2016

CFTR is a tumor suppressor gene in murine and human intestinal cancer.

B L N Than, J F Linnekamp, T K Starr, D A Largaespada, A Rod, Y Zhang, V Bruner, J Abrahante, A Schumann, T Luczak and 11 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Oncogene, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 93 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 1 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 1 synthesis or guideline pooled it, 169 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Investigating the Association Between Cystic Fibrosis and Colorectal Neoplasia: A Matched Case-Control Study.JGH open : an open access journal of gastroenterology and hepatology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The function of chloride channels in digestive system disease (Review).International journal of molecular medicine · 2025
    Review
  11. Article
  12. Imaging of cystic fibrosis manifestations in the abdomen.Abdominal radiology (New York) · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The ageing of people living with cystic fibrosis: what to expect now?European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

B L N ThanDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, USA.
J F LinnekampLaboratory of Experimental Oncology and Radiobiology, Center for Experimental Molecular Medicine, Academic Medical Center, Amsterdam, the Netherlands.
T K StarrDepartment of Genetics, Cell Biology and Development, Center for Genome Engineering, Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, MN, USA.
D A LargaespadaDepartment of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA.
A RodDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, USA.
Y ZhangUniversity of Minnesota Supercomputing Institute, Minneapolis, MN, USA.
V BrunerDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, USA.
J AbrahanteDepartment of Genetics, Cell Biology and Development, Center for Genome Engineering, Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, MN, USA.
A SchumannDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, USA.
T LuczakDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, USA.
J WalterDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, USA.
A NiemczykDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, USA.
M G O'SullivanCollege of Veterinary Medicine, University of Minnesota, St Paul, MN, USA.
J P MedemaLaboratory of Experimental Oncology and Radiobiology, Center for Experimental Molecular Medicine, Academic Medical Center, Amsterdam, the Netherlands.
R J A FijnemanDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
G A MeijerDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
E Van den BroekDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
C A HodgesDepartment of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
P M ScottDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, USA.
L VermeulenLaboratory of Experimental Oncology and Radiobiology, Center for Experimental Molecular Medicine, Academic Medical Center, Amsterdam, the Netherlands.ORCID 0000-0002-6066-789X
R T CormierDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, USA.
University of Minnesota, Duluth · USAmsterdam UMC Location University of Amsterdam · NLUniversity of Minnesota Medical Center · USThe Netherlands Cancer Institute · NLUniversity of Minnesota · USAmsterdam UMC Location Vrije Universiteit Amsterdam · NLUniversity School · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
Translational Research in Cystic FibrosisP30DK027651 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI DRUMM, MITCHELL L · 1986 to 2014
$15.6M
Sleeping Beauty for uncovering cancer genes in miceR01CA113636 · NCI · UNIVERSITY OF MINNESOTA · PI LARGAESPADA, DAVID ANDREW · 2006 to 2016
$2.5M
Transposon-based screens for colorectal cancer genesR01CA134759 · NCI · UNIVERSITY OF MINNESOTA · PI CORMIER, ROBERT T, LARGAESPADA, DAVID ANDREW · 2009 to 2013
$1.5M
Cancer gene discovery using Sleeping Beauty transposon-mediated mutagenesisR00CA151672 · NCI · UNIVERSITY OF MINNESOTA · PI STARR, TIMOTHY KAEHLER · 2011 to 2013
$710k
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA077598NCI NIH HHS R00 CA151672NCI NIH HHS R01 CA113636NCI NIH HHS R01 CA134759NIDDK NIH HHS P30 DK027651
6 · The paper itself

Abstract

CFTR, the cystic fibrosis (CF) gene, encodes for the CFTR protein that plays an essential role in anion regulation and tissue homeostasis of various epithelia. In the gastrointestinal (GI) tract CFTR promotes chloride and bicarbonate secretion, playing an essential role in ion and acid-base homeostasis. Cftr has been identified as a candidate driver gene for colorectal cancer (CRC) in several Sleeping Beauty DNA transposon-based forward genetic screens in mice. Further, recent epidemiological and clinical studies indicate that CF patients are at high risk for developing tumors in the colon. To investigate the effects of CFTR dysregulation on GI cancer, we generated Apc(Min) mice that carried an intestinal-specific knockout of Cftr. Our results indicate that Cftr is a tumor suppressor gene in the intestinal tract as Cftr mutant mice developed significantly more tumors in the colon and the entire small intestine. In Apc(+/+) mice aged to ~1 year, Cftr deficiency alone caused the development of intestinal tumors in >60% of mice. Colon organoid formation was significantly increased in organoids created from Cftr mutant mice compared with wild-type controls, suggesting a potential role of Cftr in regulating the intestinal stem cell compartment. Microarray data from the Cftr-deficient colon and the small intestine identified dysregulated genes that belong to groups of immune response, ion channel, intestinal stem cell and other growth signaling regulators. These associated clusters of genes were confirmed by pathway analysis using Ingenuity Pathway Analysis and gene set enrichment analysis (GSEA). We also conducted RNA Seq analysis of tumors from Apc(+/+) Cftr knockout mice and identified sets of genes dysregulated in tumors including altered Wnt β-catenin target genes. Finally we analyzed expression of CFTR in early stage human CRC patients stratified by risk of recurrence and found that loss of expression of CFTR was significantly associated with poor disease-free survival.

Indexed as

Genes, Tumor SuppressorAnimalsColonColorectal NeoplasmsCystic Fibrosis Transmembrane Conductance RegulatorDisease-Free SurvivalGene DeletionGene Expression Regulation, NeoplasticHumansMiceMutationSignal TransductionCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID26751771
PMCPMC4940277
OpenAlexW2234614402

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.